LeadIQ logo
Learn more at LeadIQ.com

Insights

Award-winning Technology Kuros Biosciences' MagnetOs Flex Matrix received the 2022 Spine Technology Award, highlighting its innovative bone graft extender for posterolateral spine surgeries. This recognition offers a competitive edge in marketing to healthcare providers seeking cutting-edge solutions.

Global Expansion Opportunities The successful launch of MagnetOs in selected European countries, alongside strong sales growth in the U.S., indicates a ripe opportunity for Kuros Biosciences to further expand its market presence internationally. Targeting markets where spinal surgeries are prevalent could drive significant revenue growth.

Experienced Leadership Team With the recent appointments of Daniel Geiger as CFO and Chris Fair as COO, Kuros Biosciences has fortified its leadership team. Leveraging the expertise of these seasoned executives can enhance credibility during sales pitches, particularly while engaging with key decision-makers in healthcare institutions.

Robust Clinical Evidence Kuros Biosciences boasts an impressive track record with over 10 well-controlled clinical trials, >25 orthobiologics-related patents, and >15,000 patients successfully treated. Such robust scientific evidence provides a compelling narrative for sales representatives to showcase the efficacy and reliability of the company's products to potential clients.

Market Differentiation Through Technology By utilizing a tech stack that includes Microsoft Excel, Python, and YouTube, alongside proprietary technologies like MagnetOs and Vitoss BA2X, Kuros Biosciences can position itself as a technologically advanced player in the medical equipment manufacturing industry. Leveraging this technological edge can attract tech-savvy healthcare providers looking for innovative solutions.

Similar companies to Kuros Biosciences

Kuros Biosciences Tech Stack

Kuros Biosciences uses 8 technology products and services including Microsoft Excel, jQuery Migrate, HubSpot, and more. Explore Kuros Biosciences's tech stack below.

  • Microsoft Excel
    Editors
  • jQuery Migrate
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • Python
    Programming Languages
  • X-XSS-Protection
    Security
  • YouTube
    Video Players
  • Apache HTTP Server
    Web Servers
  • Twitter
    Widgets

Media & News

Kuros Biosciences's Email Address Formats

Kuros Biosciences uses at least 1 format(s):
Kuros Biosciences Email FormatsExamplePercentage
Last@kurosbio.comDoe@kurosbio.com
58%
First.Last@kurosbio.comJohn.Doe@kurosbio.com
36%
First.MiddleLast@kurosbio.comJohn.MichaelDoe@kurosbio.com
4%
First.Middle.Last@kurosbio.comJohn.Michael.Doe@kurosbio.com
2%

Frequently Asked Questions

Where is Kuros Biosciences's headquarters located?

Minus sign iconPlus sign icon
Kuros Biosciences's main headquarters is located at Wagistrasse 25 Schlieren, Zurich 8952 CH. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is Kuros Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Kuros Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Kuros Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Kuros Biosciences's official website is kurosbio.com and has social profiles on LinkedIn.

How much revenue does Kuros Biosciences generate?

Minus sign iconPlus sign icon
As of August 2024, Kuros Biosciences's annual revenue reached $35M.

What is Kuros Biosciences's NAICS code?

Minus sign iconPlus sign icon
Kuros Biosciences's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Kuros Biosciences have currently?

Minus sign iconPlus sign icon
As of August 2024, Kuros Biosciences has approximately 100 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Executive Officer: C. F.Chief Development Officer (cdo): P. S.Chief Operating Officer: C. F.. Explore Kuros Biosciences's employee directory with LeadIQ.

What industry does Kuros Biosciences belong to?

Minus sign iconPlus sign icon
Kuros Biosciences operates in the Medical Equipment Manufacturing industry.

What technology does Kuros Biosciences use?

Minus sign iconPlus sign icon
Kuros Biosciences's tech stack includes Microsoft ExceljQuery MigrateHubSpotPythonX-XSS-ProtectionYouTubeApache HTTP ServerTwitter.

What is Kuros Biosciences's email format?

Minus sign iconPlus sign icon
Kuros Biosciences's email format typically follows the pattern of . Find more Kuros Biosciences email formats with LeadIQ.

How much funding has Kuros Biosciences raised to date?

Minus sign iconPlus sign icon
As of August 2024, Kuros Biosciences has raised $6.2M in funding. The last funding round occurred on Sep 15, 2022 for $6.2M.
Kuros Biosciences

Kuros Biosciences

Medical Equipment ManufacturingZurich, Switzerland51-200 Employees

Spine-related pain is taking a huge toll on our society: more bed-days, more days off work, and at a greater financial cost to westernized healthcare than any other condition. We’re on a mission to ease this burden through superior biologics for better spinal fusions. 

We believe that a greater quality and quantity of science holds the key to easing the burden of back surgery. Every day, we put our 150 years’ combined research experience to work in achieving this, which includes: 

10 well-controlled Level I-III clinical trials initiated.
>25 orthobiologics-related patents.
>400 patients evaluated in Level I, randomized controlled clinical trials. 
>15,000 patients successfully treated.

Today, nearly 1 in 5 spinal fusions fail. But what can we do to change this situation - for the benefit of patients, surgeons and our wider society?  This is the question that drives us at Kuros. Every day our team works across three continents to unlock the hidden secrets of bone healing through our research, development & technology program: Project Fusion. To deliver the ideal bone graft, we believe you need the highest quality & quantity of scientific evidence behind it. Which is why Project Fusion brings together an unprecedented blend of scientific, pre-clinical and clinical studies – all aimed at making the unpredictable…predictable.

CONTACT KUROS TO FIND OUT MORE >>>>

Section iconCompany Overview

Headquarters
Wagistrasse 25 Schlieren, Zurich 8952 CH
Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $6.2M

    Kuros Biosciences has raised a total of $6.2M of funding over 9 rounds. Their latest funding round was raised on Sep 15, 2022 in the amount of $6.2M.

  • $10M$50M

    Kuros Biosciences's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $6.2M

    Kuros Biosciences has raised a total of $6.2M of funding over 9 rounds. Their latest funding round was raised on Sep 15, 2022 in the amount of $6.2M.

  • $10M$50M

    Kuros Biosciences's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.